Status:

RECRUITING

Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in New Aquitaine.

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Smoking Cessation

Pregnancy Related

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The investigators are conducting a pragmatic cluster randomized trial in stepped-wedge of which objectives are to evaluate the effectiveness and the conditions of effectiveness of an organizational st...

Detailed Description

In France, in 2016, 16.6% of pregnant women were smokers, the highest levels among European countries. Pregnancy is considered a teachable moment for smoking cessation. There are many tools, intervent...

Eligibility Criteria

Inclusion

  • In this research, there are 4 categories of research participants:
  • Healthcare professionals: the target of the 5A-QUIT-N intervention from whom data will be collected to meet the secondary objective of the effectiveness conditions.
  • Stakeholders: individuals involved in the implementation of the research and intervention from whom data will be collected to meet the secondary objective of the effectiveness conditions.
  • Women who have just given birth and who smoke tobacco in early pregnancy: indirect beneficiaries of the intervention, from whom data will be collected to meet the primary objective of effectiveness.
  • Co-parent (partner) of the new-born child of the woman who has just given birth included in the study
  • Inclusion criteria for the intervention
  • The inclusion criteria for the clusters are :
  • \- Territory of maternity attractiveness in New Aquitaine
  • The inclusion criteria for care providers within the clusters are:
  • All institutions, structures and organizations and health professionals likely to participate in the follow-up of pregnant women
  • All institutions, structures and organizations and health professionals specializing in addictology or tobaccoology
  • The inclusion criteria for pregnant women within the clusters are :
  • \- All pregnant women who have smoked tobacco (at least 2 times a week, for at least 1 week) during the pregnancy (including the period when she was unaware of the pregnancy)
  • Inclusion criteria for the primary objective measures:
  • The inclusion criteria for women are (for data collection):
  • Have given birth in a New Aquitaine maternity hospital,
  • Reside in New Aquitaine
  • To have been followed for the pregnancy in the territory of the maternity of delivery
  • To have used tobacco during (at least 2 times a week, for at least 1 week) the pregnancy (including the period when she was unaware of the pregnancy)
  • Be over 18
  • Have given free, informed and express consent
  • Exclusion criteria:
  • Non-inclusion criteria for the intervention
  • Cluster non-inclusion criteria:
  • Pilot territory (territory of attractiveness of the Arcachon maternity hospital)
  • Impossibility of collecting the main judgment criterion in the cluster Within these clusters, the health care providers and the pregnant women are all concerned and therefore do not have any non-inclusion criteria.
  • Non-inclusion criteria of measures for the primary objective:
  • The criteria for non-inclusion of women who have just given birth are:
  • Not speaking French,
  • Have COVID during delivery
  • Use only electronic cigarettes,
  • Under legal protection (guardianship, curatorship, safeguard of justice)
  • Women giving birth under X
  • Women giving birth to a stillborn baby
  • Women having made a denial of pregnancy
  • Women who have their child in neonatal intensive care
  • Women who have been fully monitored for their pregnancy outside of New Aquitaine

Exclusion

    Key Trial Info

    Start Date :

    October 3 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 31 2026

    Estimated Enrollment :

    4505 Patients enrolled

    Trial Details

    Trial ID

    NCT05355012

    Start Date

    October 3 2022

    End Date

    May 31 2026

    Last Update

    October 25 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CHU de Bordeaux, Hôpital Saint-André

    Bordeaux, France, 33000